NewLink Genetics Q3 EPS $(0.39) Misses $(0.27) Estimate

NewLink Genetics (NASDAQ:NLNK) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.27) by 44.44 percent. This is a 95 percent decrease over losses of $(0.2) per share from

Benzinga · 11/06/2019 13:13

NewLink Genetics (NASDAQ:NLNK) reported quarterly losses of $(0.39) per share which missed the analyst consensus estimate of $(0.27) by 44.44 percent. This is a 95 percent decrease over losses of $(0.2) per share from the same period last year.